TRUMY News and Press, Terumo Corp. ADR From 08/12/23

2023-08-12 10:03:32 ET Terumo Corporation (TRUMF) Q1 2024 Earnings Conference Call Aug 9, 2023 4:15 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer and Group Executive Officer Conference Call Participants Presentation ...

2023-05-16 15:32:10 ET Terumo Corporation (TRUMF) Q4 2023 Results Conference Call May 15, 2023 04:30 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Antoinette Gawin - President & Chief Executive Officer Presentation N...

Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures PR Newswire – Findings show intra-vascular access via the radial artery can successfully be used as the primary strate...

Summary Haemonetics surpassed sell-side expectations with healthy revenue growth from Plasma and Hospital, but margin leverage was lacking due to the ongoing impact of inflation and supply chain issues. The company extended its non-exclusive supply agreement with CSL for another two yea...

Terumo Corporation (TRUMF) Q3 2023 Earnings Conference Call February 09, 2023, 03:00 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Presentation Naoki Muto Hello. I am the CAFO, Muto. I wi...

Summary DexCom is young, innovative, admired, and (consequently) highly valued. Embecta is old, lethargic, lacks coverage, and (consequently) lowly valued. Growth and value investors may find respective equities interesting. I use DXCM and EMBC as a lens to view developments in ...

Palm Beach, FL – January 12, 2023 – FinancialNewsMedia.com News Commentary – The drug delivery system is a device that enables the introduction of a drug in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs ...

Terumo Corporation A. (TRUMF) Q2 2022 Earnings Conference Call November 10, 2022 07:00 AM ET Company Participants Shinjiro Sato - President & Chief Executive Officer Naoki Muto - Chief Accounting & Financial Officer Conference Call Participants ...

The following slide deck was published by Terumo Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Terumo Corporation 2022 Q3 - Results - Earnings Call Presentation

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography PR Newswire –  Researchers used Terumo Health Outcomes' ePRISM®...